What is Leerink Partnrs’ Estimate for ACAD Q1 Earnings?
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of ACADIA Pharmaceuticals in a research report issued on Thursday, February 27th. Leerink Partnrs analyst M. Goodman expects that the biopharmaceutical company will post earnings per share of $0.04 for the quarter. The consensus […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of ACADIA Pharmaceuticals in a research report issued on Thursday, February 27th. Leerink Partnrs analyst M. Goodman expects that the biopharmaceutical company will post earnings per share of $0.04 for the quarter. The consensus […]
